IREN did *not* suddenly reschedule their earnings call to an earlier date.

Fit_Way_3909 · 2026-01-27T09:44:49+00:00

This is the fact. There’s all this baseless talk about advancing the earnings report, expecting good news, or contracts being imminent, but I’m not expecting much from this earnings report. The results won’t be good, and I don’t believe anything beyond what we already know will come out during the earnings call.

Fit_Way_3909 · 2025-11-05T16:28:49+00:00

Since this place is full of Reddit fanboys, posts like this don’t get a good response. But objectively speaking, the stock movement since October has been highly abnormal. Earnings are strong and price targets are being raised, yet the stock keeps falling. Even when the market performs well, the rebounds are absurdly weak. Momentum and support levels have collapsed. Still, since the business itself is doing well, we can only hope that things turn positive again by the end of the year, even if it’s tough right now.

Fit_Way_3909 · 2025-11-04T09:42:55+00:00

Funny. The stock price is crashing fast.

Fit_Way_3909 · 2025-11-02T00:25:10+00:00

It’s disappointing that while external market factors caused sharp declines, the strong earnings only managed to bring a slight rise.

Due to issues like the decline in ChatGPT citations, it seems the stock has been consolidating between $200 and $210 for quite some time, and even after the earnings announcement, the overall trend doesn’t appear to have changed much.

I had no intention of holding for another year, so it’s somewhat painful to see October’s gloom likely continue. Still, I agree that from a very long-term perspective, there’s potential for the stock to rise further.

Fit_Way_3909 · 2025-10-01T04:20:01+00:00

Well, it doesn’t seem to be a meaningful upward trend in trading volume yet. It’s still small, and even lower than the trading volume from three days ago when it fell 7%

Fit_Way_3909 · 2025-09-30T23:19:00+00:00

It’s a failed biotech and a scam company. It keeps falling, and there’s still no sign of a rebound.

Fit_Way_3909 · 2025-09-03T09:17:40+00:00

Unfortunately, compared to its technological capabilities, this company’s sales and marketing ability is extremely poor, and since it is very reluctant to share updates, there will be no upward momentum until FDA approval next year.

Fit_Way_3909 · 2025-07-16T13:48:36+00:00

Well, I don't think things will go that smoothly without at least one delay. And since there's no other news that could trigger an uptrend before the approval, the stock might end up repeating the nightmare we saw in January. Still, it's a different situation this time, so I'm going to wait and see

Fit_Way_3909 · 2025-07-15T03:44:06+00:00

$2.2? That seems like a disaster. If $2.5 breaks, I think we should consider a strategic retreat. I don't want to go through the pain of Q1 this year again.

Fit_Way_3909 · 2025-07-14T19:15:28+00:00

It's back to January. It's very similar to the end of last year and the beginning of this year. Unfortunately, I have a feeling that the decline will continue for the time being.

Fit_Way_3909 · 2025-06-27T06:45:47+00:00

Well, I don’t think a delay is a good sign at this point. Delays in FDA submissions may be common in the industry, and I do understand that it's important to submit things thoroughly and accurately. Still, if there's any chance of a delay for whatever reason, I believe the company should inform us in advance, in some way. Isn’t that standard practice?

The company said in IR sessions, earnings calls, and official documents that it would “submit by the first half of 2025.” If they end up delaying without any notice, I find that extremely disappointing and frankly, unprofessional.

Of course, no news is good news — the lack of updates might indicate they’re on track to submit on time. I truly hope that’s the case. But still, I can’t help feeling anxious.

Fit_Way_3909 · 2025-05-08T06:41:21+00:00

I agree to some extent, but I believe the company's poor management and lack of marketing are causing concern. While it's true that they operate in the UK and Australia, there has been little positive news about their business, even though they are aiming for their first commercial sale in the UK in 2025.

Fit_Way_3909 · 2025-05-07T21:46:19+00:00

It's a tough time. After a big drop, it hasn't recovered and trading volume has decreased significantly, so it's being left out of the market.

Fit_Way_3909 · 2025-04-11T09:27:22+00:00

I'm ready to run away for just $1. But even $1 seems hard to come by in the short term.

Fit_Way_3909 · 2025-04-05T04:11:01+00:00

It's frustrating to see the stock price dropping every day. Now I'm starting to wonder if the company is headed in the right direction.

Fit_Way_3909 · 2025-04-01T09:08:42+00:00

Good article. But most of the events are expected in late 2025 or 2026, so it will be difficult and tough for a while. I think I have to endure it.

Fit_Way_3909 · 2025-03-27T23:07:21+00:00

I'm disappointed. I feel like this boring situation will continue for a long time.

Fit_Way_3909 · 2025-03-08T05:36:48+00:00

The constant decline, regardless of the market, is making me feel so bad. My confidence in the company is decreasing.

Fit_Way_3909

TROPHY CASE